Psychiatry 49 abstracts.
January 2, 2004
1
Community mental health teams (CMHTs) for people with severe mental illnesses and disordered personality (Cochrane Review)
2
Cytidinediphosphocholine (CDP choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly (Cochrane Review)
3
Zuclopenthixol acetate in the treatment of acute schizophrenia and similar serious mental illnesses (Cochrane Review)
4
Reminiscence therapy for dementia (Cochrane Review)
5
Tricyclic drugs for depression in children and adolescents (Cochrane Review)
6
Seclusion and restraint for people with serious mental illnesses (Cochrane Review)
7
Psychosocial and pharmacological treatments for deliberate self harm (Cochrane Review)
8
Electroconvulsive therapy for the depressed elderly (Cochrane Review)
9
Day hospital versus out-patient care for psychiatric disorders (Cochrane Review)
10
Open general medical wards versus specialist psychiatric units for acute psychoses (Cochrane Review)
11
Day hospital versus admission for acute psychiatric disorders (Cochrane Review)
12
Assertive community treatment for people with severe mental disorders (Cochrane Review)
13
Low dosage tricyclic antidepressants for depression (Cochrane Review)
14
Treatment of Lennox-Gastaut syndrome (Cochrane Review)
15
Individual psychotherapy in the outpatient treatment of adults with anorexia nervosa (Cochrane Review)
16
Depot fluphenazine for schizophrenia (Cochrane Review)
17
Cognitive behaviour therapy for schizophrenia (Cochrane Review)
18
Psychotherapy for bulimia nervosa and binging (Cochrane Review)
19
Olanzapine for schizophrenia (Cochrane Review)
20
Parent-training programmes for improving maternal psychosocial health (Cochrane Review)
21
Carbamazepine for cocaine dependence (Cochrane Review)
22
Clotiapine for acute psychotic illnesses (Cochrane Review)
23
Family and parenting interventions in children and adolescents with conduct disorder and delinquency aged 10-17 (Cochrane Review)
24
'As required' medication regimens for seriously mentally ill people in hospital (Cochrane Review)
25
Art therapy for schizophrenia or schizophrenia-like illnesses (Cochrane Review)
26
27
Case management for people with severe mental disorders (Cochrane Review)
28
Amantadine in Parkinson's disease (Cochrane Review)
29
Antipsychotic medication for challenging behaviour in people with learning disability (Cochrane Review)
30
Supported housing for people with severe mental disorders (Cochrane Review)
31
Psychosocial treatment programmes for people with both severe mental illness and substance misuse (Cochrane Review)
32
33
Aspirin for vascular dementia (Cochrane Review)
34
Interventions for smoking cessation in hospitalised patients (Cochrane Review)
35
Cyclophosphamide versus methylprednisolone for treating neuropsychiatric involvement in systemic lupus erythematosus (Cochrane Review)
36
37
Pharmacological management for agitation and aggression in people with acquired brain injury (Cochrane Review)
38
Pharmacological treatments for psychosis-related polydipsia (Cochrane Review)
39
Cholinesterase inhibitors for dementia with Lewy bodies (Cochrane Review)
40
Antidepressants for treating depression in dementia (Cochrane Review)
41
Transcutaneous Electrical Nerve Stimulation (TENS) for dementia (Cochrane Review)
42
Transcranial magnetic stimulation for the treatment of obsessive-compulsive disorder (Cochrane Review)
43
Anticholinergics for symptomatic management of Parkinsonīs disease (Cochrane Review)
44
Vitamin B12 for cognition (Cochrane Review)
45
The effect of vitamin B6 on cognition (Cochrane Review)
46
Galantamine for Alzheimer's disease (Cochrane Review)
47
Mefloquine for preventing malaria in non-immune adult travellers (Cochrane Review)
48
Therapies for Depression in Parkinson's Disease (Cochrane Review)
49
Aroma therapy for dementia (Cochrane Review)